| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0009 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |